If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Ent-Ezetimibe Ketone
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1376615-01-8Ent-Ezetimibe Ketone

● In Stock

Catalogue No.:VE009622
CAS No.:1376615-01-8
Mol. Formula:C24H19F2NO3
Mol. Weight:407.42 g/mol

Additional information on CAS 1376615-01-8

Parent drug

Ezetimibe

IUPAC Name

(3S, 4R)-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-(4-hydroxyphenyl)-2-azetidinone

Synonyms

N/A

Description

Ent-Ezetimibe Ketone (CAS No: 1376615-01-8) Or (3S,4R)-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-(4-hydroxyphenyl)-2-azetidine, Ezetimibe is a cholesterol absorption inhibitor, which is used to treat high blood cholesterol by inhibiting the absorption of cholesterol and phytosterol. it acts to bind to the sterol-sensing domain of NPC1L1.

References

Hammersley, D., & Signy, M. (2016). Ezetimibe: an update on its clinical usefulness in specific patient groups. Therapeutic Advances in Chronic Disease, 8(1), 4–11. https://doi.org/10.1177/2040622316672544

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form